Question 1

How many shares of CHRS does ProShare Advisors LLC own?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC holds 22,172 shares of CHRS (COHERUS ONCOLOGY INC).

Question 2

What is ProShare Advisors LLC's CHRS position worth?

Accepted Answer

As of 2026-Q2, ProShare Advisors LLC's CHRS position is worth $31,040.

Question 3

Is ProShare Advisors LLC buying or selling CHRS?

Accepted Answer

In 2026-Q2, ProShare Advisors LLC increased their CHRS position (+2.2% change in shares).

Question 4

When did ProShare Advisors LLC first buy CHRS?

Accepted Answer

Based on available 13F filings, ProShare Advisors LLC first reported a position in CHRS in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	22,172	+2.2%	$31,040	0.0%	$1.40	14
2026-Q1	Decreased	21,700	-12.2%	$36,674	0.0%	$1.65	0
2025-Q4	Increased	24,718	+36.3%	$35,099	0.0%	$1.41	26
2025-Q3	Decreased	18,135	-16.6%	$29,741	0.0%	$1.70	0
2025-Q2	Decreased	21,748	-10.6%	$15,904	0.0%	$0.74	0
2025-Q1	Decreased	24,331	-22.4%	$19,635	0.0%	$0.84	0
2024-Q4	Increased	31,335	+12.6%	$43,242	0.0%	$1.50	23
2024-Q3	Increased	27,831	+31.6%	$28,945	0.0%	$1.05	25